The University of Chicago Header Logo

Connection

Andrzej Jakubowiak to Drug Costs

Back to Details
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Drug Costs.
Andrzej Jakubowiak
Connection Strength
0.148
Drug Costs
  1. Cost-effectiveness of carfilzomib plus dexamethasone compared with bortezomib plus dexamethasone for patients with relapsed or refractory multiple myeloma in the United States. Expert Rev Hematol. 2017 12; 10(12):1107-1119.
    View in: PubMed
    Score: 0.148
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.